Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocuphire Pharma Inc (OCUP)

Ocuphire Pharma Inc (OCUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ocuphire Pharma Inc 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 USA

www.ocuphire.com Employees: 14 P: 248-957-9024

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.

Key Statistics

Overview:

Market Capitalization, $K 30,331
Enterprise Value, $K -20,169
Shares Outstanding, K 25,924
Float, K 23,669
% Float 91.30%
Short Volume Ratio 0.39
% of Insider Shareholders 8.70%
% of Institutional Shareholders 14.97%

Financials:

Annual Sales, $ 19,050 K
Annual Net Income, $ -9,990 K
Last Quarter Sales, $ 1,110 K
Last Quarter Net Income, $ -7,770 K
EBIT, $ -15,080 K
EBITDA, $ -15,070 K

Growth:

1-Year Return -59.38%
3-Year Return -70.30%
5-Year Return -86.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 08/13/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -0.55
EPS Growth vs. Prev Qtr -3.45%
EPS Growth vs. Prev Year -25.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/06/20

OCUP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -30.19%
Return-on-Assets % -27.55%
Profit Margin % -52.44%
Debt/Equity 0.00
Price/Sales 1.83
Price/Cash Flow N/A
Price/Book 0.75
Book Value/Share 1.57
Interest Coverage -0.17
60-Month Beta 0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar